Toronto, Ontario / April 4, 2018 – Cannvas MedTech Inc. (“Cannvas” or the “Company”), a leading business technology company within the health sciences space, is pleased to announce the appointment of Mr. Miroslav Beganovic, CA, CPA, as CFO of the Company. Additionally, the Company is pleased to announce the appointment of Marco Contardi and Lindsay Hamelin as members of the board of directors of the Company. To facilitate these changes, Christopher Cherry has resigned as CFO and a director of the Company.
“We thank Christopher for his contributions to the Company and we wish him well in his future endeavours” said Shawn Moniz, the Company’s CEO. “We are thrilled to have Miroslav join the Cannvas team and we are fortunate to have a financial professional of his caliber assume the role of CFO. His extensive experience in corporate accounting and strategic planning make him a valuable member of the executive team as we move forward with both our anticipated CSE listing and the Company’s global initiatives.”
“I am both honoured and eager to move forward in the role of CFO at Cannvas,” said Beganovic. “The Company has accomplished an impressive amount in a short time and I look forward to working with the entire Cannvas team as we move toward with our anticipated CSE listing and the launch of Cannvas.me.”
Mr. Beganovic is a designated CA, CPA who has worked for several public accounting firms including Ernst and Young LLP and Crowe Soberman LLP where he provided services in Assurance, Audit and Taxation, and he was involved with numerous financial statement audits of Canadian subsidiaries of foreign listed corporations. Mr. Beganovic became a fully standalone practitioner in 2014.
Marco Contardi is a graduate of Osgoode Hall Law School, and a member of the Ontario Bar Association and the Law Society of Upper Canada. He is General Counsel of a vertically integrated corporation within the manufacturing and retail sectors. Marco has extensive transactional experience within the corporate/commercial realms from, both, a legal and mercantile perspective. Mr.Contardi possesses demonstrable acumen in dealing with concerns associated with production, processing, and marketing activities, especially within governmentally mandated regulatory frameworks. Marco has extensive experience advising and managing the structuring and implementing of acquisitions, joint ventures, strategic relationships, and corporate and project financings. Mr. Contardi advises on a wide range of complex long-term supply and other commercial agreements and arrangements.
Lindsay Hamelin has over 12 years experience in leading Canadian securities firms. Ms. Hamelin works with a team in charge of creating, managing and orchestrating public company requirements that span multiple levels of Canadian government regulations. Their team’s focus is mainly on the CSE, TSX, and TSXV securities exchanges. Her career started in boutique and mid-sized law firms in the greater Vancouver and downtown area. Through consistent delivery of excellence, Ms. Hamelin quickly grew her career into being the lead for providing assistance to in-house legal counsel abroad in a top-tier law firm in London, England, focusing in the corporate finance and securities industry. After a few years of having European experience under her belt, her career path brought her back to Canadian shores where she uses her international expertise to forge through complex handlings of corporate compliance matters and IPO preparations for the Canadian markets.
About Cannvas MedTech Inc.
Headquartered in Toronto, Ontario with an office in Vancouver, British Columbia, Cannvas is a leading business technology company within the health sciences space. Cannvas designs and builds customer-centric initiatives in the medtech sector that enable its partners to harness the power of data to truly understand their customers.
ON BEHALF OF THE BOARD OF DIRECTORS
Shawn Moniz, CEO Cannvas MedTech Inc.
For additional information:
W: www.cannvasmedtech.com E: firstname.lastname@example.org T: 1-800-489-0116
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.